consulting
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | AUSTIN STADCO LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — | |
| 2026 | AUSTIN STADCO LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2025 | AUSTIN STADCO LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | — | |
| 2025 | AUSTIN STADCO LLC |
4th Quarter (Oct 1 - Dec 31) Registration |
— | — | |
| 2009 | SMITH &NEPHEW INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
— | — | |
| 2009 | RESMED |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$10,000 | — | |
| 2009 | TYCO HEALTHCARE GROUP LP DBA COVIDIEN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$10,000 | — | |
| 2009 | AMGEN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$10,000 | — | |
| 2009 | ALLERGAN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$10,000 | — | |
| 2009 | SMITH &NEPHEW INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| ASSOCIATION OF COMMUNITY CANCER CENTERS | 10 | — |
| AMGEN | 9 | $160,000 |
| ALLERGAN | 9 | $150,000 |
| RESMED | 8 | $80,000 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 6 | $130,000 |
| MCKESSON HEALTH SOLUTIONS | 6 | $55,000 |
| SMITH &NEPHEW INC. | 6 | — |
| EMPI INC | 5 | $110,000 |
| SCHERING PLOUGH | 5 | $50,000 |
| MEDIMMUNE INC | 5 | — |
| AUSTIN STADCO LLC | 4 | $120,000 |
| TYCO HEALTHCARE GROUP LP DBA COVIDIEN | 4 | $30,000 |
| WYETH PHARMACEUTICALS | 2 | $60,000 |
| BIONICARE MEDICAL TECHNOLOGIES INC | 2 | $40,000 |
| AMYLIN PHARMACEUTICALS | 2 | — |
| CYTOMEDIX INC | 1 | — |
| Name | Disclosed Prior Position |
|---|---|
| GRANT BAGLEY | |
| KELLY BARNES | |
| MICHAEL BEEBE | |
| LAUREL LINDSTROM | N/A |
| MARC B SAMUELS | N/A |
| LAUREL A TODD | N/A |